complete or
integrate acquisitions and developments successfully; risks and
uncertainties affecting property development and construction; risks
associated with downturns in the national and local economies, increases in
interest rates, and volatility in the securities markets; potential
liability for uninsured losses and environmental contamination; risks
associated with the company's potential failure to qualify as a REIT under
the Internal Revenue Code of 1986, as amended, and possible adverse changes
in tax and environmental laws; and risks associated with the company's
dependence on key personnel whose continued service is not guaranteed. For
a further list and description of such risks and uncertainties, see the
reports filed by the company with the Securities and Exchange Commission,
including the company's most recent annual report on Form 10-K and
quarterly reports on Form 10-Q. The company disclaims any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
BIOMED REALTY TRUST, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
September 30, December 31,
2007 2006
(Unaudited)
ASSETS
Investments in real estate, net $2,742,603 $2,457,538
Investment in unconsolidated partnerships 21,741 2,436
Cash and cash equivalents 18,424 25,664
Restricted cash 10,003 6,426
Accounts receivable 3,722 5,985
Accrued straight-line rents, net 32,012 20,446
Acquired above-mar
'/>"/>
SOURCE BioMed Realty Trust, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Related medicine news :1.
Response Biomedical appoints S. Wayne Kay Chief Executive Officer2.
Biomedtex Inc. Announces A. Marc Rocca as President and CEO3.
Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?4.
Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors5.
BioMed Realty Trust to Report 2007 Third Quarter Results6.
BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant7.
Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange8.
Universal Health Realty Income Trust Announces Dividend9.
Healthcare Realty Trust Announces Public Offering of Common Stock10.
New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 811.
AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care